Lumos Pharma Inc
Biotechnology
Healthcare
LUMO
8.16 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
3.18
52 week high
5.17
high
3.22
52 week low
2.63
previous Close
3.18
P/E ratio
-3
market cap
23.94 M
div yield
0
net incoming
-8.93 M
-34.16 %
net profit margin
-1694.69 %
-731.00 %
operating incoming
-9.64 M
-20.01 %
net change in cash
-8.93 M
25.38 %
cash on hand
37.86 M
-14.02 %
top